BI-4020 is an Orally Active EGFR Tyrosine Kinase Inhibitor
The epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase that transduces mitogenic signals. When EGFR carries an activating mutation, it can be an oncogenic driver in lung tumors.…